Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) EBT (2019 - 2025)

Volitionrx (VNRX) has disclosed EBT for 9 consecutive years, with -$5.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT fell 10741.53% year-over-year to -$5.1 million, compared with a TTM value of -$16.4 million through Sep 2025, up 32.19%, and an annual FY2024 reading of -$27.0 million, up 24.74% over the prior year.
  • EBT was -$5.1 million for Q3 2025 at Volitionrx, down from $29992.0 in the prior quarter.
  • Across five years, EBT topped out at $94092.0 in Q4 2022 and bottomed at -$9.5 million in Q2 2023.
  • Average EBT over 5 years is -$3.5 million, with a median of -$47049.0 recorded in 2024.
  • The sharpest move saw EBT soared 791.1% in 2022, then tumbled 12585.14% in 2023.
  • Year by year, EBT stood at $73088.0 in 2021, then grew by 28.74% to $94092.0 in 2022, then plummeted by 9380.53% to -$8.7 million in 2023, then soared by 33.8% to -$5.8 million in 2024, then increased by 11.77% to -$5.1 million in 2025.
  • Business Quant data shows EBT for VNRX at -$5.1 million in Q3 2025, $29992.0 in Q2 2025, and -$5.5 million in Q1 2025.